Attach Patient Banda Label hereShared Care Agreement • July 15th, 2021Contract TypeShared Care AgreementFiledJuly 15th, 2021Atomoxetine: for the treatment of children of 6 years of age and older with attention deficit/hyperactivity disorder (ADHD)
Atomoxetine: for the treatment of children of 6 years of age and older with attention deficit/hyperactivity disorder (ADHD)